Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Cancer-killing combo: Viagra and the flu vaccine

Posted on June 6th, 2018 by in Pharma R&D

“Strange bedfellows” doesn’t even begin to describe the drug combination that a new study published in OncoImmunology suggests may actually work together to combat cancer. Continue reading “Cancer-killing combo: Viagra and the flu vaccine” »

Extreme Makeover: Clinical Trials Edition

Posted on December 4th, 2017 by in Pharma R&D

In a piece featured in the PharmaTimes, Katrina Megget points out the sad state of affairs when it comes to clinical trials, highlighting some appalling stats on the frequent failure to reach enrollment targets (in some cases, not finding any patients at all) and the tendency for studies to go on far longer than anticipated. Continue reading “Extreme Makeover: Clinical Trials Edition” »

Seeking Other Perspectives to Tease Out New Innovations

Posted on November 22nd, 2017 by in Pharma R&D

On October 24, Astellas Oncology announced the five finalists in its C3 Prize competition, chosen from over 160 entrants who submitted their ideas on how to improve the cancer care experience through non-medicine innovations. Continue reading “Seeking Other Perspectives to Tease Out New Innovations” »

Getting Personal: Better Diagnosis, Better Treatment

Posted on September 8th, 2017 by in Pharma R&D

Figures released by the U.S. National Cancer Institute (NCI) in 2017 indicate that the burden of cancer is on the rise, with the number of diagnoses rising by 50% over the next 13 years. Even more troubling is the predicted mortality rate for cancer, Continue reading “Getting Personal: Better Diagnosis, Better Treatment” »

  1. 1
  2. 2
  3. 3
  4. 4